Stock Events

Stock Events

Spyre Therapeutics (3920.STU) Q3 2026 Earnings

6AugConfirmed

Q1 2026

Q2 2026

Next

-0.63

-0.61

-0.59

-0.57

Details

Expected EPS

-0.63006772608

Actual EPS

N/A

Surprise EPS

0.63

Surprise Percent

+100%

Description

Spyre Therapeutics (3920.STU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.